|
MCID: LKM009
|
Leukemia/lymphoma, B-cell, 2 malady |
|
Sources: 22MalaCards See all sources Export this MalaCard |
MalaCards: Leukemia/lymphoma, B-cell, 2, also known as leukemia, is related to leukemia and myeloid leukemia. An important gene associated with Leukemia/lymphoma, B-cell, 2 is BCL2 (B-cell CLL/lymphoma 2). The drugs isotretinoin and pipobroman have been mentioned in the context of this disorder. Affiliated tissues include b cells.
|
|
Sources: 43UMLS, 33OMIM See all sources |
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for leukemia/lymphoma, b-cell, 2 Drug clinical trials:Search ClinicalTrials for leukemia/lymphoma, b-cell, 2 Search NIH Clinical Center for leukemia/lymphoma, b-cell, 2 Search CenterWatch for leukemia/lymphoma, b-cell, 2 Inferred drug relations via UMLS/NDF-RT:43 28 cytarabine, cytarabine liposome, doxorubicin hydrochloride, irinotecan, irinotecan hydrochloride, isotretinoin, methotrexate, methotrexate sodium, pipobroman, vincristine, vincristine sulfate |
|
|
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to leukemia/lymphoma, b-cell, 2:22B cells
|
|
|
|
|
|
Sources: 1BioGPS See all sources |
![]() |
|
|
|
|
|
|
